Functional polymorphism of the MMP-1 promoter (-1607 1G/2G) in potentially malignant and malignant head and neck lesions in an Indian population

References

• Barlas IO, Sezgin M, Erdal ME et al. (2009). Association of (-1607) 1G/2G polymorphism of matrix metalloproteinase-1 gene with knee osteoarthritis in the Turkish population (Knee osteoarthritis) and MMPs gene polymorphisms. RheumatolInt 29:383–8.
   Google Scholar
• Brinkerhoff CE, Rutter JL, Benbow U. (2000).Interstitial collagenases as markers of tumor progression. Clin Cancer Res 6:4823–30.
   PubMedGoogle Scholar
• Cao ZG, Li CZ. (2006). A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter enhances oral squamous cell carcinoma susceptibility in a Chinese population. Oral Oncol 42:32–8.
   Google Scholar
• Chaudhary AK, Singh M, Bharti AC, Asotra K, Sundaram S, Mehrotra R. (2010).Genetic polymorphisms of matrix metalloproteinases and their inhibitors in potentially malignant and malignant lesions of the head and neck. J Biomed Sci 17:10.
   PubMed Web of Science ®Google Scholar
• Chaudhary AK, Singh M, Sundaram S, Mehrotra R. (2009). Role of human papilloma virus and its detection in potentially malignant and malignant head and neck lesions: updated review. Head Neck Oncol 1:22.
   PubMedGoogle Scholar
• Checa M, Ruiz V, Montaño M et al. (2008). MMP-1 polymorphisms and the risk of idiopathic pulmonary fibrosis. Hum Genet 124:465–72.
   PubMed Web of Science ®Google Scholar
• Fujimoto T, Parry S, Urbanek M et al. (2002). A single nucleotide polymorphism in the matrix metalloproteinase-1 (MMP-1) promoter influences amnion cell MMP-1 expression and risk for preterm premature rupture of the fetal membranes. J Biol Chem 277:6296–302.
   PubMed Web of Science ®Google Scholar
• Gomez DE, Alonso DF, Yoshiji H, Thorgeirsson UP. (1997). Tissue inhibitors of metalloprotienases: structure, regulation and biological functions. Eur J Cell Biol 74:111–22.
   PubMed Web of Science ®Google Scholar
• Hanahan D, Weinberg RA. (2000). The hallmarks of cancer. Cell 100:57–70.
   PubMed Web of Science ®Google Scholar
• Hashimoto T, Uchida K, Okayama N, Imate Y, Suehiro Y, Hamanaka Y et al. (2004) Association of matrix metalloproteinase (MMP)-1 promoter polymorphism with head and neck squamous cell carcinoma. Cancer Lett 211:19–24.
   PubMed Web of Science ®Google Scholar
• Hettiaratchi A, Hawkins NJ, McKenzie G et al. (2007).The collagenase-1 (MMP-1) gene promoter polymorphism - 1607/2G is associated with favourable prognosis in patients with colorectal cancer. Br J Cancer 96:783–92.
   PubMed Web of Science ®Google Scholar
• Kanamori Y, Matsushima M, Minaguchi T, Patel SG, Shah JP et al. (1999). TNM staging of cancers of the head and neck: striving for uniformity among diversity. Cancer Res 59:4225–7.
   PubMed Web of Science ®Google Scholar
• Kerkela E, Saarialho-Kere U. (2003). Matrix metalloproteinases in tumor progression: focus on basal and squamous cell skin cancer. Experimental dermatology 12(2): 109–125.
   Google Scholar
• Lai SC, Chu CM, Lin YW et al. (2005). Matrix metalloproteinase 1 gene polymorphism as a prognostic predictor of invasive cervical cancer. Gynecol Oncol 96:314–19.
   PubMed Web of Science ®Google Scholar
• Lambert E, Dasse E, Haye B, Petitfrere E. (2004). TIMPs as multifacial proteins. Crit Rev Oncol Hematol 49:187–198.
   PubMed Web of Science ®Google Scholar
• Lin SC, Lo SS, Liu CJ, Chung MY. (2004). Functional genotype in matrix metalloproteinases-2 promoter is a risk factor for oral carcinogenesis. Oral Pathol Med 33:323–6.
   Google Scholar
• Llewellyn CD, Johnson NW, Warnakulasuriya KA. (2001). Risk factors for squamous cell carcinoma of the oral cavity in young people – a comprehensive literature review. Oral Oncol 37:401–18.
   PubMedGoogle Scholar
• McColgan P, Sharma P. (2009). Polymorphisms of matrix metalloproteinases 1, 2, 3 and 9 and susceptibility to lung, breast and colorectal cancer in over 30,000 subjects. Int J Cancer 125:1473–8.
   PubMed Web of Science ®Google Scholar
• Nasr HB, Mestiri S, Chahed K. (2007). Matrix metalloproteinase-1 (-1607) 1G/2G and -9 (-1562) C/T promoter polymorphisms: susceptibility and prognostic implications in nasopharyngeal carcinomas.ClinChimActa 384:57–63.
   Google Scholar
• Nishioka Y, Kobayashi K, Sagae S et al. (2000). A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter in endometrial carcinomas. Jpn J Cancer Res 91:612–15.
   PubMedGoogle Scholar
• Nishioka Y, Sagae S, Nishikawa A et al. (2003). A relationship between Matrix metalloproteinase-1 (MMP-1) promoter polymorphism and cervical cancer progression. Cancer Lett 200:49–55.
   Google Scholar
• Nishizawa R, Nagata M, Noman AA. (2007).The 2G allele of promoter region of Matrix metalloproteinase-1 as an essential pre-condition for the early onset of oral squamous cell carcinoma. BMC Cancer 7:187.
   Google Scholar
• O-charoenrat P, Leksrisakul P, Sangruchi S. (2006). A functional polymorphism in the matrix metalloproteinase-1 gene promoter is associated with susceptibility and aggressiveness of head and neck cancer. Int J Cancer 118:2548–53.
   Google Scholar
• Overall CM, Lopez-Otin C. (2002).Strategies for MMP inhibition in cancer: innovations for the post-trial era. Nat Rev Cancer 2:657–72.
   PubMed Web of Science ®Google Scholar
• Patel SG, Shah JP. (2005). TNM staging of cancers of the head and neck: striving for uniformity among diversity. CA Cancer J Clin 55:242–58.
   PubMed Web of Science ®Google Scholar
• Pindborg JJ, Sirsat SM. (1966). Oral submucous fibrosis. Oral Surg Oral Med Oral Pathol 22:764–79.
   PubMedGoogle Scholar
• Przybylowska K, Kluczna A, Zadrozny M et al. (2006). Polymorphisms of the promoter regions of matrix metalloproteinases genes MMP-1 and MMP-9 in breast cancer. Breast Cancer Res Treat 95:65–72.
   PubMed Web of Science ®Google Scholar
• Rutter JL, Mitchell TI, Buttice G et al. (1998). A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter creates an Ets binding site and augments transcription. Cancer Res 58:5321–5.
   PubMed Web of Science ®Google Scholar
• Shan K, Ying W, Jian-Hui Z et al. (2005). The function of the SNP in the MMP1 and MMP3 promoter in susceptibility to endometriosis in China. Mol Hum Reprod 11:423–7.
   Web of Science ®Google Scholar
• Shimizu Y, Kondo S, Shirai A. (2008). A single nucleotide polymorphism in the matrix metalloproteinase-1 and interleukin-8 gene promoter predicts poor prognosis in tongue cancer. Auris Nasus Larrynx 35:381–9.
   Google Scholar
• Tower GB, Coon CC, Benbow U et al. (2002). Erk 1/2 differentially regulates the expression from the 1G/2G single nucleotide polymorphism in the MMP-1 promoter in melanoma cells. Biochim Biophys Acta 1586:265–74.
   Google Scholar
• Tu HF, Liu CJ, Chang CS et al. (2006). The functional (-1171 5A/6A) polymorphisms of matrix metalloproteinase 3 as a risk factor for oral submucous fibrosis among areca users. J Oral Pathol Med 35:99–103.
   Google Scholar
• Tu HF, Wu CH, Kao SY et al. (2007). Functional -1562 C-to-T polymorphism in matrix metalloproteinase-9 (MMP-9) promoter is associated with the risk for oral squamous cell carcinoma in younger male areca users. J Oral Pathol Med 36:409–14.
   PubMed Web of Science ®Google Scholar
• Vairaktaris E, Serefoglou Z, Avgoustidis D et al. (2009). Gene polymorphisms related to angiogenesis, inflammation and thrombosis that influence risk for oral cancer. Oral Oncol 45(3): 247–53.
   Google Scholar
• Vairaktaris E, Yapijakis C, Derka S. (2007). Association of matrix metalloproteinase-1 (-1607 1G/2G) polymorphism with increased risk for oral squamous cell carcinoma. Anticancer Res 27:459–64.
   PubMed Web of Science ®Google Scholar
• Westermarck J,Kahari VM. (1999). Regulation of matrix metalloproteinase expression in tumour invasion.FASEB 13:781–92.
   PubMed Web of Science ®Google Scholar
• Zhu Y, Spitz MR, Lei L et al. (2001). A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter enhances lung cancer the susceptibility. Cancer Res 61:7825–9.
   PubMed Web of Science ®Google Scholar
• Zinzindohoué F, Blons H, Hans S, Loriot MA, Houllier AM, Brasnu D et al. (2004). Single nucleotide polymorphisms in MMP1 and MMP3 gene promoters as risk factor in head and neck squamous cell carcinoma. Anticancer Res 24:2021–6.
   Google Scholar
• Ziober BL, Turner MA, Palefsky JM. (2000).Type I collagen degradation by invasive oral squamous cell carcinoma. Oral Oncol 36:365–72.
   Google Scholar